Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ørngreen, M. C.
Right arrow Articles by Vissing, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ørngreen, M. C.
Right arrow Articles by Vissing, J.
Related Collections
Right arrow Nutritional
Right arrow Muscle disease

Neurology 2003;61:559-561
© 2003 American Academy of Neurology


Brief Communications

Effect of diet on exercise tolerance in carnitine palmitoyltransferase II deficiency

Mette C. Ørngreen, BS, Rasmus Ejstrup, BS and John Vissing, MD PhD

From the Copenhagen Muscle Research Center and Department of Neurology, National University Hospital, Rigshospitalet, Denmark.

Address correspondence and reprint requests to Dr. J. Vissing, Department of Neurology 2082, National University Hospital, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; e-mail: vissing{at}rh.dk

It is generally believed that a diet high in carbohydrate improves exercise tolerance in patients with carnitine palmitoyltransferase II (CPT II) deficiency, but it has never been systematically investigated. The authors investigated the effect of a high- vs low-carbohydrate diet on exercise tolerance in four patients with CPT II, who cycled at a constant workload of 50% of VO2max. Exercise tolerance, assessed by exercise duration and perceived exertion, improved on the carbohydrate-rich diet.




This article has been cited by other articles:


Home page
Arch NeurolHome page
T. D. Jeppesen, M. C. Orngreen, G. van Hall, R. G. Haller, and J. Vissing
Fat Metabolism During Exercise in Patients With Mitochondrial Disease
Arch Neurol, March 1, 2009; 66(3): 365 - 370.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S T Andersen and J Vissing
Carbohydrate- and protein-rich diets in McArdle disease: effects on exercise capacity
J. Neurol. Neurosurg. Psychiatry, December 1, 2008; 79(12): 1359 - 1363.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. R. Roe, B-Z Yang, H. Brunengraber, D. S. Roe, M. Wallace, and B. K. Garritson
Carnitine palmitoyltransferase II deficiency: Successful anaplerotic diet therapy
Neurology, July 22, 2008; 71(4): 260 - 264.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Deschauer, T. Wieser, and S. Zierz
Muscle Carnitine Palmitoyltransferase II Deficiency: Clinical and Molecular Genetic Features and Diagnostic Aspects
Arch Neurol, January 1, 2005; 62(1): 37 - 41.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.